Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
207,440,936
-
Number of holders
-
143
-
Total 13F shares, excl. options
-
62,444,882
-
Shares change
-
+7,947,418
-
Total reported value, excl. options
-
$418,381,560
-
Value change
-
+$53,328,619
-
Put/Call ratio
-
22%
-
Number of buys
-
77
-
Number of sells
-
48
-
Price
-
$6.70
Institutional Holders of Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) as of Q3 2022
As of 30 Sep 2022 Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) had 143 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 62,444,882 shares of stock of the company.
Largest 10 holders included WASATCH ADVISORS INC, Deep Track Capital, LP, BlackRock Inc., Meditor Group Ltd, Bellevue Group AG, VANGUARD GROUP INC, Point72 Asset Management, L.P., Ikarian Capital, LLC, MILLENNIUM MANAGEMENT LLC, and Paradigm Biocapital Advisors LP.
This table shows 143 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.